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ABSTRACT Nonencapsulated Streptococcus pneumoniae (NESp) is an emerging hu-
man pathogen that colonizes the nasopharynx and is associated with noninvasive
diseases such as otitis media (OM), conjunctivitis, and nonbacteremic pneumonia.
Since capsule expression was previously thought to be necessary for establishment
of invasive pneumococcal disease (IPD), serotype-speciﬁc polysaccharide capsules are
targeted by currently licensed pneumococcal vaccines. Yet, NESp expressing oligo-
peptide binding proteins AliC and AliD have been isolated during IPD. Thus, we hy-
pothesize AliC and AliD are major NESp virulence determinants that facilitate persis-
tence and development of IPD. Our study reveals that NESp expressing AliC and
AliD have intensiﬁed virulence compared to isogenic mutants. Speciﬁcally, we dem-
onstrate AliC and AliD enhance murine nasopharyngeal colonization and pulmonary
infection and are required for OM in a chinchilla model. Furthermore, AliC and AliD
increase pneumococcal survival in chinchilla whole blood and aid in resistance to
killing by human leukocytes. Comparative proteome analysis revealed signiﬁcant al-
terations in protein levels when AliC and AliD were absent. Virulence-associated pro-
teins, including a pneumococcal surface protein C variant (CbpAC), were signiﬁcantly
downregulated, while starvation response indicators were upregulated in the double
mutant relative to wild-type levels. We also reveal that differentially expressed
CbpAC was essential for NESp adherence to epithelial cells, virulence during OM, re-
duction of C3b deposition on the NESp surface, and binding to nonspeciﬁc IgA. Al-
together, the rise in NESp prevalence urges the need to understand how NESp es-
tablishes disease and persists in a host. This study highlights the roles of AliC, AliD,
and CbpAC in the pathogenesis of NESp.
IMPORTANCE Despite the effective, widespread use of licensed pneumococcal vac-
cines over many decades, pneumococcal infections remain a worldwide burden re-
sulting in high morbidity and mortality. NESp subpopulations are rapidly rising in
the wake of capsule-targeted vaccine strategies, yet there is very little knowledge on
NESp pathogenic potential and virulence mechanisms. Although NESp lacks a pro-
tective capsule, NESp lineages expressing AliC and AliD have been associated with
systemic infections. Furthermore, higher antibiotic resistance rates and transforma-
tion efﬁciencies associated with emerging NESp threaten treatment strategies
needed to control pneumococcal infections and transmission. Elucidating how NESp
survives within a host and establishes disease is necessary for development of
broadened pneumococcal prevention methods. Our study identiﬁes virulence deter-
minants and host survival mechanisms employed by NESp with a high pathogenic
potential. Moreover, our study also identiﬁes virulence determinants shared by NESp
and encapsulated strains that may serve as broad prevention and therapeutic tar-
gets.
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Streptococcus pneumoniae (pneumococcus) colonizes the human nasopharynx andcauses a wide variety of diseases such as otitis media (OM), pneumonia, bacteremia,
and meningitis following dissemination from the nasopharynx (1, 2). Notably, pneu-
mococci are the leading cause of bacterial pneumonia, OM, and bacterial meningitis
and are the primary reason for unscheduled pediatrician visits for children less than 5
years old (3, 4). Additionally, high morbidity and mortality are associated with pneu-
mococcal infections in the elderly (5). Preventative measures against pneumococcal
disease include a 13-valent pneumococcal conjugate vaccine (PCV) and 23-valent
polysaccharide vaccine that target speciﬁc polysaccharide capsules of the pneumococ-
cus (6). Since there are 97 known pneumococcal serotypes, the current vaccines confer
protection against a limited number of serotypes (7). Furthermore, pneumococcal
vaccines do not prevent pneumococcal disease caused by nonencapsulated S. pneu-
moniae (NESp), as this subpopulation lacks capsule expression. Although substantial
decreases in disease associated with serotypes included in the current vaccines have
been observed, an increase in the isolation of nonvaccine serotypes and NESp have
been reported following the use of these vaccines (8–11). Consequently, selective
pressure against the polysaccharide capsule provided by current vaccines has likely
driven the increase in NESp colonization and disease establishment.
Three genes (pspK, aliC, and aliD) that replace capsule synthesis genes encoded in
the capsule polysaccharide biosynthetic (cps) locus have been identiﬁed in NESp strains
(12, 13). The replacement of capsule genes with novel genes in NESp suggests that the
proteins encoded by these genes provide functions that may compensate for lack of
capsule production. PspK has been described as an adhesin that allows NESp to
colonize as efﬁciently as encapsulated pneumococci (14, 15). Remarkably, extensive
surveillance of invasive pneumococcal disease (IPD) isolates has revealed an association
of invasive disease with NESp expressing oligopeptide binding proteins AliC and AliD
despite the absence of a protective, antiphagocytic capsule thought to be necessary to
establish IPD (12, 16–20). A survey of pneumococcal isolates in Switzerland from 1998
to 2002 ﬁrst exposed the isolation of NESp expressing AliC and AliD from a blood
sample (12). Surveillance of IPD isolates in the United States from 2006 to 2009
identiﬁed that 67% of pneumococcal isolates lacking cps genes encoded both aliC and
aliD in their cps locus (19). In a surveillance study spanning 2003 to 2013 in South Africa,
82% of NESp IPD isolates with complete deletion of cps genes were described as
containing aliC and aliD in place of their cps genes (20). Collectively, the isolation of
IPD-associated NESp expressing AliC and AliD from geographically distinct areas of
isolation suggests that these oligopeptide binding proteins afford a selective advan-
tage during invasive disease.
Sequence analyses and previous studies have indicated that AliC and AliD are
substrate binding proteins that concentrate small, extracellular oligopeptides at the
bacterial surface and deliver the substrates to transmembrane permeases for substrate
import (12, 13, 21, 22). Analysis has also revealed AliC and AliD to be orthologous to
outer membrane proteins of the OppA family found in Gram-negative bacteria (23, 24).
Currently, a comprehensive understanding of how AliC and AliD inﬂuence NESp
physiology and virulence has yet to be established. Oligopeptides are commonly
imported by Gram-positive bacteria as sensory molecules that alter expression of
numerous virulence factors, such as hemolysins, adhesins, and genes responsible for
bioﬁlm formation (25). Outer membrane proteins in Gram-negative bacteria that are
homologous to AliC and AliD have been shown to be signiﬁcant effectors of nutrient
acquisition and complement evasion (24, 26). On the basis of IPD surveillance data and
sequence homology analysis, we hypothesize that oligopeptide transport involving
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AliC and AliD enhances the pathogenic potential of NESp by altering protein expression
that aids in bacterial persistence.
Here, we describe the impact of AliC and AliD on NESp virulence by examining in vitro
virulence-associated phenotypes and investigating these oligopeptide binding proteins
during in vivo models of pathogenesis. We demonstrate that AliC and AliD are signiﬁcant
factors in colonization of the murine nasopharynx and lungs, disease progression during
OM in a chinchilla model, survival within chinchilla whole blood, and evasion of host
immune responses encountered during invasive disease. We also reveal that a NESp surface
adhesin CbpAC, which is homologous to encapsulated pneumococcal surface protein C,
enhances virulence during mucosal infections and provides a host evasion mechanism.
RESULTS
NESp bioﬁlm biomass is reduced by the presence of AliC and AliD. Bioﬁlm
formation and pneumococcal viability were quantiﬁed to determine whether the
absence of AliC or AliD resulted in differences in community growth phenotypes (Fig. 1;
also see Fig. S1A in the supplemental material). We investigated NESp carriage isolates
MNZ85 and MNZ41 of differing sequence types, 2315 and 6153, respectively (Table 1).
FIG 1 Bioﬁlm biomass is reduced in vitro by the presence of AliC and AliD. (A) Bioﬁlm formation was quantiﬁed at 24 h after seeding
a 24-well plate with 105 pneumococci and corresponds to wild-type strains MNZ85 and MNZ41 set to 100% formation. The strain
backgrounds are indicated by the color key. (B) Pneumococcal viability in the bioﬁlm was assessed at 24 h by collecting bioﬁlms and
plating on BA to enumerate CFU. In panels A and B, values are means plus standard errors of the means (error bars) from at least two
independent studies performed in triplicate. Values that are signiﬁcantly different are indicated by asterisks as follows: *, P  0.05; **,
P  0.01. (C) Micrographs of 24-h bioﬁlms stained with crystal violet and captured at 10 magniﬁcation. Deletion of aliC and aliD
signiﬁcantly increased bioﬁlm formation in both strain backgrounds (A and C) but did not affect NESp viability in bioﬁlms (B).
NESp Virulence Is Increased by AliC and AliD ®
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Also, isogenic aliC and aliD double deletion mutants of strains MNZ85 and MNZ41,
LEK08 and JLB01, respectively, were analyzed. Signiﬁcant increases (P 0.05) in bioﬁlm
formation (Fig. 1A) were observed when aliC and aliD were deleted in MNZ85 and
MNZ41 backgrounds. Although bioﬁlm formation increased with a single deletion of
aliC or aliD in strain MNZ41 (Fig. 1A), only a single deletion of aliD signiﬁcantly
increased (P  0.05) bioﬁlm formation. Increased bioﬁlm formation was not a direct
result of increased pneumococcal viability in the bioﬁlms, as there were no signiﬁcant
differences in NESp cell densities in either strain background when aliC and aliD were
deleted (Fig. 1B). NESp aggregation and presence of biomass towers as visualized in
stained bioﬁlms were enhanced when aliC and aliD were absent from both back-
grounds (Fig. 1C).
AliC and AliD diminish adherence to epithelial cells but do not affect NESp
invasion rates. Pneumococcal adherence and invasion of epithelial cells were exam-
ined to assess whether AliC and AliD altered bacterial interactions with host cells at the
cell-to-cell interface (Fig. 2 and Fig. S1B). Two different human cell lines, Detroit 562
pharyngeal cells (Fig. 2A and B) and A549 pulmonary cells (Fig. 2C and D), were utilized
to mimic two speciﬁc niches for colonization and establishment of pneumococcal
disease. A deletion of aliC and aliD did not alter NESp MNZ85 adherence to pharyngeal
cells (Fig. 2A) or pulmonary epithelial cells (Fig. 2B). However, MNZ41 adherence to
pharyngeal and pulmonary cells signiﬁcantly increased (P  0.01) when aliC and aliD
were deleted (Fig. 2A and C), with increased adherence to pharyngeal cells also being
observed when aliC alone was deleted (Fig. 2A). MNZ85 and MNZ41 cells invaded
pulmonary cells more efﬁciently than pharyngeal cells, but the presence of AliC and
AliD did not alter invasion rates in either epithelial cell line (Fig. 2B and D).
The intracellular level and cytolytic activity of pneumolysin are increased by
the presence of AliD in virulent strain MNZ41. Pneumolysin (Ply) is a pneumococcal
virulence factor that lacks a secretion signal and functions as a cholesterol-dependent
cytolysin of host cells (27). Intracellular Ply levels were quantiﬁed by an enzyme-linked
immunosorbent assay (ELISA) to determine whether oligopeptide transport through
AliC and AliD affected Ply production (Fig. 3A and Fig. S1C). A deletion of both aliC and
aliD resulted in a highly signiﬁcant decrease (P  0.001) in the intracellular Ply level
compared to that of strain MNZ41, and this effect was also observed with a single
deletion of aliD (Fig. 3A). A hemolysis assay was also utilized to determine whether
TABLE 1 Descriptions of pneumococcal strains used in this study
Serotype Sequence type Strain Strain description or relevant genotype Antibiotic resistancea Reference
NESp 2315 MNZ85 Carriage isolate ND 13
LEK08 MNZ85 ΔaliC ΔaliD Spec
(300 g/ml)
This study
NESp 6153 MNZ41 Carriage isolate Tmp
(50 g/ml)
13
JLB01 MNZ41 ΔaliC ΔaliD Spec
(300 g/ml)
This study
JLB02 MNZ41 ΔaliC Kan
(500 g/ml)
This study
JLB04 MNZ41 ΔaliD Spec
(300 g/ml)
This study
JLB10 MNZ41 ΔcbpAC Spec
(300 g/ml)
This study
2 595 D39 Avery’s virulent isolate ND 57
ΔPAC D39 Δply ΔpspA ΔpspC Tmp, Tet, and Erm
(10 g/ml, 5 g/ml,
and 0.3 g/ml,
respectively)
31
19F 43 EF3030 Otitis media isolate ND 58
aND, not determined; Spec, spectinomycin; Tmp, trimethoprim; Kan, kanamycin; Tet, tetracycline; Erm, erythromycin.
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FIG 2 NESp adherence and invasion of human epithelial cells. Detroit 562 pharyngeal (A and B) or A549 pulmonary (C and D)
epithelial cells were incubated with 107 pneumococci. Adhered or intracellular bacteria were enumerated by plating on BA. A deletion
of aliC and aliD in MNZ41 signiﬁcantly increased adherence to both cell lines (A and C) but did not affect invasion into epithelial cells
(B and D). Values are means plus standard errors of the means (error bars) from three independent studies performed in triplicate.
Values that are signiﬁcantly different are indicated by asterisks as follows: *, P  0.05; **, P  0.01; ***, P  0.001.
FIG 3 AliD impacts pneumolysin (Ply) levels and activity. (A) Intracellular Ply levels were determined by using equivalent protein
concentrations of NESp lysates in an indirect ELISA, and Ply levels were standardized to the levels for strain MNZ41 set at 100%. Ply activity
was quantiﬁed by incubating sheep red blood cells (RBCs) with standardized NESp lysates and measuring RBC lysis. Lysis by Triton X-100
(TX-100) was set at 100%, and PBS served as the negative control for lysis. In panels A and B, a deletion of aliD resulted in a signiﬁcant
decrease in Ply production and activity. At least two independent studies were performed, and each strain was tested in triplicate. Error
bars represent standard errors of the means. Values that are signiﬁcantly different are indicated by asterisks as follows: **, P  0.01; ***,
P  0.001.
NESp Virulence Is Increased by AliC and AliD ®
January/February 2018 Volume 9 Issue 1 e02097-17 mbio.asm.org 5
 
m
bio.asm
.org
 o
n
 April 9, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
differences in Ply levels correlated with cytolytic activity (Fig. 3B and Fig. S1D). Similar
to ELISA results (Fig. 3A), lysing of red blood cells was signiﬁcantly reduced (P  0.01)
when AliD was absent (Fig. 3B).
AliC and AliD enhance murine nasopharyngeal colonization and pulmonary
infection. We utilized a C57BL/6 murine model to assess whether differences in
adhesion correlated with the ability to colonize the murine nasopharynx and establish
an active lung infection. Signiﬁcantly higher counts of bacteria were recovered from the
mouse nasopharynx when AliC and AliD were both present in the MNZ85 (P  0.05)
and MNZ41 (P  0.05) backgrounds 5 days after intranasal challenge (Fig. 4A and Fig.
S2A). A trend in decreased recovered bacteria was also observed when only aliC or aliD
was deleted in strain MNZ41. To determine the impact of oligopeptide transport
through AliC and AliD during earlier stages of colonization, we also assessed pneumo-
coccal colonization 1 and 2 days after challenge (Fig. 4B). Bacterial loads in the
nasopharynx were signiﬁcantly higher (P 0.05) 1 and 2 days after intranasal challenge
when AliC and AliD were present, with a log unit difference in recovered bacteria
observed as early as 1 day postchallenge (Fig. 4B). Since NESp was able to efﬁciently
colonize the nasopharynx, we then tested the ability of NESp MNZ41 to colonize the
FIG 4 AliC and AliD enhance nasopharyngeal colonization and pulmonary infection of C57BL/6 mice. (A and B) Nasopharyngeal wash
and tissue homogenates were plated on BA, and bacterial counts were combined to estimate log CFU/mouse at 1, 2, and 5 days after
intranasal challenge with 107 pneumococci. In panel A, each symbol represents the value for an individual mouse, and a short line
represents the mean value for that group of mice. Mean values that are signiﬁcantly different (P  0.05) are indicated by a bar and
asterisk. wt, wild type. (C) Mice were intranasally inoculated with encapsulated serotype 19F strain EF3030 and NESp strain MNZ41 at
a 1:1 mixture of 107 CFU or were inoculated with 107 CFU of each strain independently. Replica plating on selective BA was used to
enumerate recovered log CFU/mouse at 5 days postchallenge. (D) The lungs were collected 2 days after intratracheal infection with
107 pneumococci, and lung homogenates were plated on BA to enumerate CFU. AliC and AliD signiﬁcantly enhanced colonization of
the murine nasopharynx (A and B) and infection of the lungs (D). NESp was able to efﬁciently colonize the murine nasopharynx despite
cocolonization with encapsulated 19F strain (C). Each independent study was performed twice. Error bars represent standard errors
of the means.
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nasopharynx when in competition with a prevalent encapsulated strain, EF3030 (sero-
type 19F). Five days after intranasal challenge, NESp CFU recovered from mice inocu-
lated with a mixture of strains MNZ41 and EF3030 were similar to NESp CFU recovered
from a single inoculation of MNZ41 (Fig. 4C). Although previous studies have estab-
lished the ability of NESp to efﬁciently colonize the nasopharynx (12–14, 22, 28), there
is very limited evidence as to whether NESp can persist in the lung environment.
Two days after intratracheal inoculation of NESp, strain MNZ41 was recovered from the
lungs of mice, and a deletion of aliC and aliD signiﬁcantly reduced (P  0.0037)
bacterial load during an active lung infection (Fig. 4D).
Chinchilla acute OM is nearly abrogated when AliC and AliD are absent.
Virulence during otitis media (OM) was assessed through otoscopic examination and
bioﬁlm formation scoring of the middle ear postmortem (Table 2 and Fig. 5B), as well
as pneumococci recovered from each inoculated bulla 4 days postinfection (Fig. 5A and
Fig. S2B). In a chinchilla model, OM was signiﬁcantly attenuated when AliC and AliD
were absent in both MNZ85 (P 0.01) and MNZ41 (P 0.001) backgrounds. Moreover,
a single deletion of aliC or aliD resulted in signiﬁcantly decreased recovery of bacteria
(P 0.05), but did not attenuate virulence as strongly as a deletion of both aliC and aliD
TABLE 2 Chinchilla otitis media (OM) tympanic pathology and intrabullar bioﬁlm scores
Strain
Otoscopic scorea
(mean  SEM)
Bioﬁlm scoreb
(mean  SEM)
MNZ85 1.64  0.13 1.71  0.13
LEK08 0.53  0.19 0
MNZ41 2 2  0.19
JLB01 0.5  0.19 0.42  0.19
JLB02 2 1.67  0.28
JLB04 1.79  0.11 1.71  0.27
JLB10 1.75  0.25 1  0.57
aOtoscopic examination of the tympanic membrane was scored as follows: 0 for no visible inﬂammation, 1
for inﬂammation, 2 for effusion, and 3 for tympanic membrane rupture.
bBioﬁlm formation was scored as follows: 0 for no visible bioﬁlm formation, 1 for bioﬁlm formation on the
surface of bulla, 2 for the bioﬁlm traverses the bulla, and 3 for the bioﬁlm traverses the bulla with
thickening.
FIG 5 AliC and AliD increase NESp virulence during acute otitis media (OM) in chinchillas. (A) Chinchillas
received intrabullar injection of 107 pneumococci in each bulla. Middle ear effusion, bulla wash, and bulla
homogenate of individual bulla were plated on BA, and bacterial counts were combined to estimate log
CFU/bulla recovered at 4 days postinfection. (B) Representative otoscopic pictures of tympanic mem-
branes of infected chinchillas at 4 days postinfection with the pathology score shown in red in the top
rightmost corner of the picture. (A and B) Bacterial recovery and tympanic pathology were signiﬁcantly
reduced when aliC and aliD were deleted. The scoring rubric and combined tympanic pathology scores
are given in Materials and Methods and in Table 2. At least four chinchillas (n 8) were infected for each
strain, and the data shown are representative of two independent experiments. Error bars represent
standard errors of the means. Values that are signiﬁcantly different are indicated by asterisks as follows:
*, P  0.05; **, P  0.01; ***, P  0.001.
NESp Virulence Is Increased by AliC and AliD ®
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(Fig. 5A). Increased tympanic pathology and bioﬁlm formation were observed in
wild-type (wt) strains compared to isogenic double deletion mutants, but a single
deletion of aliC or aliD did not result in signiﬁcantly different otoscopic or in vivo bioﬁlm
scores (Table 2).
Pneumococcal survival after exposure to chinchilla whole blood and human
PMNs is mediated by AliC and AliD. During chinchilla OM, chinchillas infected with wt
strains displayed signs of systemic disease (lethargy, ataxia, and unresponsiveness to
sound), and NESp was recovered from the blood. To determine whether NESp was able
to survive within uninfected chinchilla whole blood, bacterial strains were incubated in
heparinized chinchilla whole blood. Percent bacterial survival was determined follow-
ing a 3-h incubation (Fig. 6A). Deletion of aliC and aliD from either strain MNZ85 or
strain MNZ41 resulted in decreased pneumococcal survival in chinchilla whole blood
(P  0.05), and MNZ41 bacterial counts increased during the incubation. A single
deletion of aliC diminished bacterial survival (P  0.01) compared to wt or double
deletions. Additionally, a single deletion of aliD further diminished bacterial survival
(P  0.001), with almost all NESp cleared after 3 h of incubation in chinchilla whole
blood. To investigate how NESp survives in whole blood, we examined pneumococcal
survival when exposed to human neutrophils (polymorphonuclear leukocytes [PMNs]),
the most abundant immune cell in blood. After 24 h of allowing PMNs and bacteria to
interact on sheep blood agar (BA), pneumococcal survival was greatly reduced when
aliC (P  0.001) or aliD (P  0.01) was deleted in the MNZ41 background (Fig. 6B).
Oligopeptide transport involving AliC and AliD alters the physiological state of
NESp and upregulates virulence-associated proteins. In vitro and in vivo models of
virulence revealed that a deletion of aliC and aliD altered phenotypes and attenuated
NESp virulence. However, these phenotypic differences were not a result of differences
in growth kinetics (Fig. S3). To examine how oligopeptide transport involving AliC and
AliD impacts bacterial physiology and interactions with the host, we employed mass
spectrometry to compare the proteomes of strains MNZ41 and JLB01. Proteomic
analysis of pneumococcal strains MNZ41 and JLB01 yielded 186 and 112 proteins,
respectively. The false-discovery rates ranged from 0.2% to 1.2% across all samples.
Differential expression analysis (Data Set S1) showed that 75 proteins were signiﬁcantly
differentially expressed (P  0.05) between strains MNZ41 and JLB01. Speciﬁcally, 12
proteins were upregulated and 63 proteins were downregulated in strain JLB01 com-
pared to strain MNZ41 levels. Proteins were grouped based on direction of regulation
FIG 6 AliC and AliD promote survival during exposure to chinchilla whole blood and human polymorphonuclear (PMN) cells.
(A) Percent survival in chinchilla whole blood was calculated by dividing the blood mixture bacterial counts at 3 h by the NESp
inoculum and multiplying by 100. (B) Pneumococcal survival after 24-h exposure to human PMNs at a PMN:bacterium ratio of
800:1 was calculated by dividing the number of CFU of PMN-treated NESp by the number of mock-treated NESp and
multiplying by 100. NESp CFU were enumerated by plating on BA. AliC and AliD signiﬁcantly increased NESp survival during
exposure to chinchilla whole blood (A) and human neutrophils (B). Data represent two independent studies performed in
triplicate. Error bars represent standard errors of the means. Values that are signiﬁcantly different are indicated by asterisks as
follows: *, P  0.05; **, P  0.01; ***, P  0.001.
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and function, and a representative list of differentially expressed proteins that may
impact NESp persistence and virulence is listed in Table 3.
NESp PspC variant CbpAC increases adherence to epithelial cells and virulence
during chinchilla OM. Comparative proteomic analysis revealed that a variant of the
encapsulated virulence protein PspC, described as CbpAC (29), was upregulated when
AliC and AliD were present. We investigated whether CbpAC was essential for increased
NESp virulence in the MNZ41 background. CbpAC signiﬁcantly increased (P  0.0001)
adherence to pharyngeal cells (Fig. 7A) and was a signiﬁcant virulence factor (P 
0.0084) during chinchilla OM (Fig. 7D). However, the NESp PspC variant did not
signiﬁcantly impact colonization of the murine nasopharynx (Fig. 7B) or infection of the
murine lung (Fig. 7C).
CbpAC prevents deposition of human complement component C3b and binds
to nonspeciﬁc mouse IgA. PspC of encapsulated pneumococci binds to host secretory
immunoglobulin A (sIgA), as well as factor H that has been shown to decrease C3b
deposition on the pneumococcal surface (30, 31). Sequence divergence predicts CbpAC
binds to the Fc portion of IgA, rather than binding to the secretory component of sIgA
(29). Furthermore, pneumococcal survival upon exposure to whole blood (Fig. 7A)
suggests that NESp has developed a mechanism to resist early innate immune respond-
ers present in blood. To assess whether CbpAC provides functions similar to encapsu-
lated PspC, we used ﬂow cytometry to examine binding of host immune factors to the
surfaces of viable pneumococci (Fig. 8). A deletion of cbpAC signiﬁcantly increased
(70.7%  3.4% positive) C3b deposition (Fig. 8A) (P  0.05) compared to C3b depos-
ited on the surface of strain MNZ41 (34.2%  3.4% positive). Strain JLB01 that
expressed CbpAC at signiﬁcantly lower levels than those of MNZ41 (Table 3) also had
increased C3b deposited on its surface (64.3%  16.1% positive) (P  0.05). However,
factor H did not inhibit C3b deposition on NESp surfaces, as NESp was not able to bind
to factor H (Fig. 8B). NESp CbpAC was also important for binding to nonspeciﬁc IgA
(Fig. 8C), as a deletion of cbpAC resulted in decreased binding to nonspeciﬁc IgA (28.4%
 20.5% positive) (P  0.001) compared to MNZ41 (58.6%  11.6% positive).
DISCUSSION
Our study demonstrates that AliC and AliD are essential for mucosal colonization
and infection. Moreover, these oligopeptide binding proteins are required for persis-
tence during invasive disease. As the pathogenic potential of NESp is poorly under-
stood, this study elucidates AliC and AliD as mediators of NESp pathogenesis. Our in
vitro analyses show that the presence of AliC and AliD results in a decrease of both
TABLE 3 Representative proteins dysregulated when AliC and AliD are absent from strain MNZ41
NCBI
accession no. Protein description Protein function
Regulation
direction
in strain JLB01 P value
EPD18890.1 Adenylate kinase ADP synthesis using ATP and AMP Up 0.029
EPD19581.1 DNA protection during
starvation protein
Oxidative damage protectant Up 0.014
EDP19576.1 Endoribonuclease L-PSP Translation initiation inhibitor Up 0.014
EPD21090.1 Acetaldehyde reductase Regeneration of NAD Up 0.014
EPD18727.1 Glutamyl aminopeptidase Glutamate synthesis Down P  0.01
EPD20852.1 Asparagine synthetase AsnA Asparagine synthesis Down P  0.01
EPD19911.1 Aspartate kinase Threonine synthesis from aspartate Down 0.012
EPD22312.1 IMP dehydrogenase De novo synthesis of guanine nucleotides Down 0.013
EPD21793.1 Uracil ribosyltransferase Pyrimidine (uracil) salvage Down 0.029
EPD18378.1 6-Phosphofructokinase Synthesis of fructose-1,6-bisphosphate in glycolysis Down P  0.01
EPD21778.1 Pyruvate oxidase (SpxB) Production of endogenous H2O2, pneumolysin release Down 0.014
EPD16767.1 GroEL Refolding of misfolded proteins under stressful
conditions
Down P  0.01
EPD19400.1 DnaK Chaperone; folding of nascent proteins and
misfolded proteins during stress
Down 0.014
EPD21629.1 NADH oxidase Protects against oxidative stress, aids in adherence Down 0.011
EPD17685.1 CbpAC (PspC variant) Surface adhesion; binding to Fc IgA Down P  0.01
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adhesion to epithelial cells and in vitro bioﬁlm formation, while increasing the expres-
sion of a critical cytolysin, Ply. These results correlate with a previous study that
revealed that invasive pneumococcal strains produce more Ply and prefer a planktonic,
less adhesive lifestyle (32). Also, the switch from an adhesive state to a more dynamic,
virulent state has been previously shown in both Gram-positive bacteria and Gram-
negative bacteria through quorum sensing coordinated with global gene regulation
(33, 34). In the majority of our studies, a deletion of both aliC and aliD resulted in
substantial phenotypic differences compared to a single deletion of aliC or aliD. Thus,
it is likely that each oligopeptide binding protein serves separate functions, which
exhibit a combined additive effect on pneumococcal physiology and sensing of exter-
nal stimuli. Furthermore, these separate functions may be advantageous within differ-
ent host compartments that provide a divergent stimulus. To our knowledge, aliC has
been found in the cps locus only in the context of aliD, but aliD has been identiﬁed in
the absence of aliC in the cps locus of encapsulated pneumococci and other Strepto-
coccus genera, suggesting that AliD provides a more essential, conserved function (13,
35). Ply production (Fig. 3A) and NESp survival in whole blood (Fig. 6A) were greatly
reduced when AliD was absent, thus signifying that AliD has a more dominant role in
invasive disease.
Our comparative proteome data (Table 3; also see Data Set S1 in the supplemental
FIG 7 NESp CbpAC improves adherence to human epithelial cells and virulence during chinchilla OM. (A) Human Detroit 562
pharyngeal epithelial cells were incubated with 107 NESp, and adhered pneumococci were enumerated by plating on BA. Adherence
assays were performed in triplicate, and data are representative of two independent studies. (B) Nasal washes and tissue homogenates
of C57BL/6 mice (n  7) intransally challenged with 107 NESp were plated on BA, and bacterial counts were combined to estimate
log CFU/mouse at 1, 2, and 5 days postinfection. (C) C57BL/6 mice (n  6) were intratracheally infected with 107 NESp, and the lungs
were collected at 2 days postinfection for bacterial enumeration. (D) Each bulla of chinchillas (n  4) was injected with 107 NESp, and
individual bulla effusion ﬂuid, wash ﬂuid, and homogenate were plated on BA to enumerate bacterial CFU at 4 days postinfection.
Effusion, bulla, and wash bacterial counts were pooled for each bulla to estimate log CFU/bulla. CbpAC signiﬁcantly increased
adherence to pharyngeal epithelial cells (A) but was not required for colonization of murine nasopharynx (B) or infection of the lungs
(C). (D) Deletion of cbpAC signiﬁcantly attenuated OM in chinchillas. Error bars denote standard errors of the means.
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FIG 8 Flow cytometry analysis of host immune factors binding to NESp surfaces. (A and B) Pneumococci were incubated with pooled normal
human serum followed by biotinylated goat anti-human C3b (A) or puriﬁed biotinylated human factor H (B). (C) Bacterial cells were incubated
with nonspeciﬁc mouse IgA followed by biotinylated goat anti-mouse IgA. The cells were subsequently stained with streptavidin-conjugated
Alexa Fluor 488 and subjected to ﬂow cytometry. A total of 50,000 events were collected, and percent positive cells was calculated by gating
ﬂuorescence higher than background. The averages of percent positive cells standard error of the mean are listed to the right of representative
histograms in overlays, and the mean ﬂuorescence intensities are represented in bar graphs. D39 is a type 2 pneumococcal strain expressing
PspC/CbpA, and ΔPAC is a D39 derivative strain with deletions of ply, pspC, and pspA. NESp CbpAC decreased human C3b deposition on NESp
surface (A), but decreased deposition was not a result of binding to human factor H (B). NESp CbpAC variant signiﬁcantly binds to nonspeciﬁc
murine IgA (C). Data are representative of two independent experiments. Error bars denote standard errors of the means. Values that are
signiﬁcantly different are indicated by asterisks as follows: *, P  0.05; ***, P  0.001.
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material) indicate that oligopeptide import involving AliC and AliD serves as both a
nutritional source and regulator of numerous virulence factors. Overall, the absence of
AliC and AliD resulted in a starvation state in JLB01 cells. Proteins involved in nucleic
acid synthesis, amino acid synthesis, protein synthesis, and protein folding were all
downregulated in strain JLB01 compared to their levels in strain MNZ41. Furthermore,
proteins involved in breaking down molecules for energy, protecting DNA during a
starvation response, and inhibiting protein translation were upregulated in JLB01 cells.
Interestingly, proteins associated with virulence in encapsulated bacteria, such as the
PspC variant (CbpAC, NCBI accession no. EPD17685.1), NADH oxidase (EPD21629.1), and
pyruvate oxidase (EPD21778.1), were upregulated in strain MNZ41 compared to strain
JLB01 (31, 36–38). However, what occurs between substrate import and phenotype
modiﬁcation through protein dysregulation remains unknown. The imported oligopep-
tide substrates may alter regulation through direct recognition of DNA or through
indirect signal transducing methods involving protein or RNA intermediates. Further
studies are needed to identify direct interactions of oligopeptide substrates with
intracellular machinery.
Even so, our in vivo data exposes the signiﬁcance of AliC and AliD in both early
colonization of a host and subsequent persistence. The presence of AliC and AliD
improved murine nasopharyngeal colonization during initial colonization and as late as
5 days postinfection (Fig. 4A and B). AliC and AliD were also shown to be essential for
persistence during an active lung infection (Fig. 4D). Likewise, chinchilla OM was
signiﬁcantly enhanced when AliC and AliD were present (Fig. 5A), with bacteremia
occurring in chinchillas infected with NESp expressing AliC and AliD. Furthermore,
virulence during OM was nearly abrogated when AliC and AliD or CbpAC alone was
absent (Fig. 5C and 7D). Factors other than increased adherence to cells are likely aiding
in colonization, as no differences in adherence to epithelial cells were observed in the
MNZ85 background and increased adherence was observed when aliC and aliD were
deleted from the MNZ41 background (Fig. 2). Also, CbpAC increased adherence to
epithelial cells but had no signiﬁcant effect on murine colonization (Fig. 7). Since NESp
invades epithelial cells at a low rate (Fig. 2) and naturally lacks a protective capsule,
NESp must be able to endure the extracellular association with pharyngeal and
pulmonary cells. In a nutrient-deprived and complete system such as the environment
in the murine nasopharynx and lungs, as well as in the chinchilla bulla, AliC and AliD
are likely altering bacterial physiology in response to the external environment. Since
there were no signiﬁcant differences in growth between strains MNZ41 and JLB01 in
vitro (Fig. S3), proteomic variances within the cells may be contributing to ﬁtness within
a host. Accordingly, increased bioﬁlm formation in wt NESp during OM (Table 2) is
probably a result of increased ﬁtness leading to increased pneumococcal densities
within the host (Fig. 5A and Fig. S2B). Additionally, Ply has been shown to be an
important factor in the initial colonization of the murine nasopharynx (39). Although Ply
was not implicated as signiﬁcantly differentially expressed during stringent proteomic
analysis (Table 3 and Data Set S1), small differences were ampliﬁed by ELISA detection
(Fig. 3A and Fig. S1C) and were shown to impact cytolytic activity (Fig. 3B and Fig. S1D).
Thus, increased Ply protein levels in strain MNZ41 in comparison to isogenic mutants
may have inﬂuenced colonization of the murine nasopharynx, allowing for a higher
recovery of pneumococci at 1 to 2 days postchallenge and enhanced persistence at
5 days postchallenge. Moreover, NADH oxidase that was upregulated in strain MNZ41
compared to that in the double mutant (Table 3) has also been shown to be important
for murine colonization and invasive disease (37). NESp CbpAC was shown to be
essential only during chinchilla OM (Fig. 7), which demonstrates that phenotypic effects
of NESp virulence factors are conditional and dependent on speciﬁc niches in the host.
Nonetheless, Ply, NADH oxidase, and PspC variants are virulence proteins shared by
pathogenic encapsulated and nonencapsulated pneumococci. Accordingly, these pro-
teins may serve as preventive and therapeutic options that target a broadened pneu-
mococcal population.
The development of systemic disease during OM in chinchillas infected with wt
Bradshaw et al. ®
January/February 2018 Volume 9 Issue 1 e02097-17 mbio.asm.org 12
 
m
bio.asm
.org
 o
n
 April 9, 2018 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
NESp gives further evidence of the signiﬁcance of AliC and AliD in NESp invasive
disease. The isolation of NESp expressing AliC and AliD during IPD cases, as well as the
observation of systemic disease in chinchillas infected by strains MNZ85 and MNZ41,
directed us to investigate possible immune evasion mechanisms that could allow NESp
to survive and even replicate in whole blood (Fig. 6A). As neutrophils are the dominant
immune cell type in blood, we chose to examine NESp interactions with neutrophils on
a deﬁned surface. Also, complement serum proteins are important mediators of innate
immunity that are deposited on the surfaces of invading bacteria (40). All pathways
of complement activation converge on complement factor C3b, resulting in op-
sonophagocytosis and clearance of invasive bacteria (41). NESp possessing AliC and
AliD were signiﬁcantly more resistant to killing by neutrophils (Fig. 6B) and exhibited
decreased C3b deposited on their surfaces (Fig. 8A) compared to isogenic mutants. Ply
has been previously shown to lyse neutrophils (42), which may be enhancing the ability
of strain MNZ41 to resist killing by neutrophils. However, other factors or biological
processes are facilitating resistance to killing by PMNs, as a deletion of aliC did not
signiﬁcantly alter Ply production (Fig. 3) but resulted in decreased NESp survival when
exposed to neutrophils. These factors or processes aiding in NESp survival may include
bacterial proteins that induce apoptosis of neutrophils or help bacterial resistance to
phagocytosis or subsequent killing. For inhibiting C3b deposition, it is probable that
AliC and AliD are able to bind to host regulators of complement deposition or that the
imported oligopeptide substrates alter expression of pneumococcal surface proteins
that bind to or function as inhibitors of complement deposition. Surprisingly, se-
quenced NESp isolates expressing AliC and AliD do not encode PspC, also known as
CbpA (43). PspC is a pneumococcal surface protein that binds host factor H, thus
allowing inhibition of C3b deposition (41, 44, 45). Since the NESp PspC variant CbpAC
was upregulated in strain MNZ41 compared to strain JLB01 (Table 3), we investigated
whether CbpAC was functioning similar to encapsulated PspC by inhibiting C3b
deposition through binding to factor H. We observed that CbpAC signiﬁcantly reduced
C3b deposition (Fig. 8A), but the decreased deposition was not a consequence of
binding to full-length factor H (Fig. 8B). Thus, NESp CbpAC may be preventing C3b
deposition by binding to truncated versions of factor H or through other mechanisms
that may be speciﬁc to one of the complement pathways before they converge on C3b
deposition. Remarkably, we were able to conﬁrm that CbpAC does bind to nonspeciﬁc
IgA (Fig. 8C), and binding of IgA may compensate for lack of capsule by creating an IgA
shield that could prevent recognition or clearance by host immune cells.
Finally, currently licensed vaccines elicit limited protection against encapsulated
pneumococci and do not prevent NESp infections. Thus, a protein-based vaccine,
including proteins expressed by both encapsulated and nonencapsulated pneumo-
cocci would confer a broader protection against invasive populations of pneumococci.
NESp bacteria with increased antibiotic resistance and mobile genetic elements are
clustering and becoming highly prevalent (29, 43, 45). Current capsule-targeted vac-
cines selecting for outgrowth of NESp subpopulations will continue to potentiate the
risk of invasive disease associated with NESp strains. Previous studies have shown that
importer orthologs of AliC and AliD are immunogenic and serve as prominent vaccine
candidates (46, 47). Hence, future studies of the immunogenicity of AliC and AliD both
exclusively and in combined formulations with other virulence proteins of pneumo-
cocci are warranted. Also, PspC immunization has been shown to be protective against
encapsulated pneumococcal disease (48). NESp strains that do not express AliC or AliD
contain the gene pspK in the capsule locus, which encodes a pneumococcal surface
protein that has high sequence identity to the R1 region of encapsulated PspC (13). A
PspC variant was shown to be upregulated in a NESp strain expressing AliC and AliD
(strain MNZ41) in comparison to the isogenic double mutant JLB01. Thus, a PspC
fragment that shares similarity in encapsulated and NESp strains may also serve as a
vaccine candidate that could elicit protection against a broader population of pneu-
mococci. Altogether, as surveillance studies continue to reveal the rapid adaption of
pneumococci and decreasing efﬁcacy of polysaccharide-targeted vaccines, studies in
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alternative immunization methods will remain a necessity for prevention of pneumo-
coccal disease.
MATERIALS AND METHODS
Bacterial growth. All pneumococcal strains were incubated at 37°C with 5% CO2 and cultured on
either sheep blood agar (BA) or in Todd-Hewitt medium with 0.5% yeast extract (THY) with respective
antibiotic selection. The strains utilized in this study and descriptions of the strains are given in Table 1.
DNA mutagenesis. Isogenic mutants of MNZ85 and MNZ41, LEK08 and JLB01, respectively, were
generated by allelic replacement of the capsule locus with a spectinomycin resistance cassette ampliﬁed
from strain LEK05 as previously described (49). MNZ41 isogenic single mutations of aliC (JLB02) and aliD
(JLB04) were created by allelic replacement of aliC or aliD with a kanamycin resistance cassette or
spectinomycin resistance cassette, respectively. An isogenic deletion of the pspC variant (cbpAC) in strain
MNZ41 (JLB10) was generated through allelic replacement of cbpAC with a spectinomycin resistance
cassette.
Bioﬁlm viability and production. A 24-well plate was seeded with 105 CFU/ml of the nonencap-
sulated Streptococcus pneumoniae (NESp) strains in bioﬁlm media (THY, 8 U/ml catalase, and 10% horse
serum) and incubated overnight. To determine bioﬁlm formation, the medium was removed from wells
after overnight growth, and bioﬁlms were stained with 350 l of 0.1% crystal violet at room temperature
for 30 min. Unbound crystal violet was carefully removed, and bioﬁlm-associated crystal violet was
solubilized by the addition of 1 ml of 100% ethanol to each well with shaking at room temperature for
10 min. Solubilized crystal violet was plated on a 96-well plate, and bioﬁlm production was determined
by reading the optical density at 630 nm (OD630). After removal of excess crystal violet, images of bioﬁlm
formation were captured at a 10 magniﬁcation using a Nikon Eclipse 50i microscope with DS camera
control unit DS-U2 (version 4.4) and NIS-Elements BR 3.0 software. To determine viability, medium was
removed from wells after overnight growth, and bioﬁlms were suspended in 500 l of phosphate-
buffered saline (PBS), serially diluted, and plated on BA to enumerate pneumococcal CFU.
Adherence and invasion of human epithelial cells. Human Detroit 562 pharyngeal (ATCC CCL-138,
obtained from Justin Thornton, Mississippi State University, USA) and A549 pulmonary (ATCC CCL-185,
obtained from Stephen Stray, University of Mississippi Medical Center, USA) epithelial cells were cultured
to approximately 90% conﬂuence (~3 105 cells/ml for Detroit 562 cells and ~1.5 105 cells/ml for A549
cells) in 10% fetal calf serum (FCS)-supplemented Eagle’s minimal essential medium (EMEM) with
100 g/ml penicillin, 50 g/ml streptomycin, and 100 g/ml amphotericin B in 24-well plates at 37°C
with 5% CO2. Human epithelial cells that had reached at least 90% conﬂuence were washed three times
with PBS. Approximately 107 pneumococci were added to each well and allowed to adhere for 30 min
or invade for 2 h at 37°C with 5% CO2. Following incubation, epithelial cells were washed three times with
PBS. To assess pneumococcal adherence, human epithelial cells were lifted with 100 l of 0.25%
trypsin-EDTA, suspended in 900 l of PBS, and plated on BA to enumerate adherent pneumococcal CFU.
For invasion, epithelial cells were incubated with 1 ml of EMEM containing 100 g/ml penicillin, 50 g/ml
streptomycin, and 100 g/ml amphotericin B for an additional hour to eliminate extracellular bacteria.
Epithelial cells were subsequently washed three times with PBS, lifted with 100 l of 0.25% trypsin-EDTA,
lysed with 100 l of cold 0.0125% Triton X-100, and plated on BA to enumerate intracellular pneumo-
cocci. Recovered pneumococcal CFU were adjusted by standardizing inocula to 107 CFU.
Ply protein production and activity. NESp strains were cultured to mid-log phase in THY, and 1 ml
of bacterial culture was pelleted. Bacterial cell lysates were prepared by suspending cell pellets in 100-l
volumes of lysis buffer (0.01% sodium dodecyl sulfate, 0.1% sodium deoxycholate, and 0.015 M sodium
citrate), incubating for 30 min at 37°C, and diluting in 100 l of PBS. Prepared lysates were standardized
to equivalent total protein concentrations by determining total protein concentration in cell lysates
through standard bicinchoninic acid (BCA) assay protocol (Sigma-Aldrich) and diluting with PBS to
equivalence. To measure intracellular Ply levels, prepared lysates were used to coat a 96-well plate in
triplicate overnight, and the coated plate was used in an indirect enzyme-linked immunosorbent assay
(ELISA) with primary rabbit anti-Ply serum (provided by Mary Marquart, University of Mississippi Medical
Center, USA). Donkey anti-rabbit IgG (GE Healthcare Life Sciences) conjugated to alkaline phosphatase
was used as the secondary antibody. The 96-well plate was read at OD405 on an xMark spectrophotom-
eter to determine Ply concentration relative to the concentration in strain MNZ41. To measure Ply
activity, standardized lysates were plated in triplicate in a 96-well round bottom plate and 50 l of 2%
sheep red blood cells (RBCs) were added to each well. PBS served as a negative control for RBC lysis, and
1% Triton X-100 served as a positive control for RBC lysis. Plated blood mixtures were incubated for
30 min at 37°C, and nonlysed RBCs were subsequently collected by centrifugation at 500  g for 5 min.
To assay for lysed RBCs, 100 l of supernatant was transferred to a 96-well ﬂat bottom plate and
spectrophotometrically measured at OD450.
Murine nasopharyngeal colonization. Six- to eight-week-old C57BL/6 mice were anesthetized with
isoﬂurane and intranasally challenged with 10 l of PBS containing 107 CFU of pneumococci. For
cocolonization studies, mice were challenged with 10 l of a 1:1 mixture containing 107 CFU of
pneumococci (5  106 CFU of EF3030 and 5  106 CFU of strain MNZ41). At 1, 2, and 5 days after
challenge, the mice were euthanized, the murine nasopharynx was washed with 200 l of PBS, and
nasopharyngeal tissue was collected. Bacterial load was enumerated by plating nasal washes and tissue
homogenates on BA with 5 g/ml gentamicin to estimate log CFU/mouse. For cocolonization studies,
nasal washes and tissue homogenates were also plated on BA containing 50 g/ml trimethoprim to
enumerate recovered MNZ41 CFU. Recovered EF3030 CFU was calculated by subtracting MNZ41 counts
from total recovered bacterial CFU enumerated on BA containing 5 g/ml gentamicin.
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Murine pulmonary infections. Adult C57BL/6 mice (weight, 20 to 25 g) were anesthetized with
500 l Avertin (6.25 mg tribromoethanol dissolved in 2.5% amylene hydrate solution) and intratracheally
inoculated with 50 l of PBS containing 107 CFU of pneumococci. The mice were euthanized, and the
lungs were collected 2 days postinfection. The lungs were homogenized in 2 ml PBS and plated on BA
to enumerate recovered log CFU/mouse.
Chinchilla acute otitis media. Pneumococcal virulence during otitis media (OM) was assessed as
previously described (49). Brieﬂy, young adult chinchillas (Chinchilla lanigera) (body weight, 400 to 500 g)
were inoculated via transbullar injection with approximately 107 CFU of pneumococci. Chinchillas were
euthanized 4 days postinfection, and tympanic pathology was assessed through otoscopic examination
and bioﬁlm formation within each bulla. Middle ear effusion was collected, each bulla was lavaged with
1 ml PBS, and each individual bulla was homogenized in 10 ml of PBS. All CFU were enumerated on BA
with 5 g/ml gentamicin. Combined effusion, lavage, and homogenate counts were used to estimate the
log CFU/bulla.
Tympanic pathology was scored through otoscopic examination both before and after infection, as
well as bioﬁlm formation after euthanasia. Otoscopic examination of the tympanic membrane was scored
as follows: 0 for no inﬂammation, 1 for inﬂammation, 2 for effusion, and 3 for tympanic rupture. Bioﬁlm
formation was scored as follows: 0 for no visible bioﬁlm formation, 1 for bioﬁlm formation on the surface
of the bulla, 2 for the bioﬁlm traverses the bulla, and 3 for the bioﬁlm traverses the bulla with thickening.
Otoscopic and bioﬁlm scores are listed in Table 2.
Chinchilla whole blood killing. Whole blood was collected from the saphenous veins of healthy
adult chinchillas. Approximately 105 CFU pneumococci were incubated in 150 l of fresh, heparinized
chinchilla whole blood, and the blood mixture was rotated end over end for 3 h at 37°C. Initial inocula
and blood mixtures following 3-h incubation were serially diluted and plated on BA with 5 g/ml
gentamicin. Percent survival was calculated by dividing the CFU enumerated after 3-h incubation by the
respective inoculum (CFU) and multiplying by 100.
Human neutrophil (PMN) surface killing. To isolate human polymorphonuclear leukocytes (PMNs),
60 ml of freshly collected human whole blood was gently mixed with 12 ml of Lymphoprep (Stemcell
Technologies) and allowed to settle for 30 min. The lymphocyte-enriched supernatant was centrifuged
at 225  g for 10 min at 25°C to collect lymphocytes. Pelleted cells were suspended in 6 ml of PBS, and
the cell suspension was overlaid on 3 ml of Lymphoprep, followed by centrifugation at 300  g for
40 min at 25°C. Hypotonic lysis to remove residual RBCs was performed by suspending cell pellets in 7-ml
volumes of ice-cold 0.2% NaCl, incubating for 25 s on ice, followed by the addition of 7 ml of 1.6% NaCl
to restore tonicity. Neutrophils were collected by centrifugation at 225  g for 10 min at 4°C, and cell
pellets were suspended in 3 ml of ice-cold Hanks balanced salt solution (HBSS). Neutrophil concentration
was enumerated using a hemocytometer and adjusted by dilution in HBSS.
Pneumococcal survival upon exposure to human neutrophils was performed as previously described
(50) with modiﬁcations. Brieﬂy, 10 l of 5  103 CFU/ml pneumococci was spotted with six replicates on
BA. After the spotted bacterial cells had dried, 20 l of 2  106 cells/ml of freshly isolated neutrophils
(multiplicity of infection [MOI] of 800) was overlaid on each bacterial replicate. A duplicate plate spotted
with pneumococci was overlaid with 20 l HBSS and served as the control. The plates were incubated
for 24 h, and pneumococcal CFU was enumerated to determine percent pneumococcal survival. Percent
survival was calculated by dividing the PMN-treated plate CFU by the control plate CFU and multiplying
by 100.
Comparative proteomic analysis. Four replicates each of pneumococcal strains MNZ41 and JLB01
were subjected to proteomic analysis. The cultures were grown to mid-log phase (OD600 of 0.25),
pelleted, and lysed with 100 l hexaﬂuoroisopropanol (HFIP). HFIP was removed using vacuum centrif-
ugation, and dried lysates were rehydrated with the addition of 10 l of 100 mM dithiothreitol (DTT) in
100 mM ammonium bicarbonate (ABC) and placed at 85°C for 5 min to reduce disulﬁde bonds. Samples
were alkylated by the addition of 10 l iodoacetamide in 100 mM ABC and placed at room temperature
in the dark for 30 min. Two micrograms of trypsin in 200 l of 100 mM ABC was added to each sample
and placed at 37°C overnight for enzymatic digestion. After trypsin digestion, samples were desalted
using a peptide reverse-phase microtrap (Michrom BioResources), dried, and suspended in 20 l of 2%
(vol/vol) acetonitrile and 0.1% (vol/vol) formic acid. A Dionex UltiMate 3000 (Thermo Scientiﬁc) high-
performance liquid chromatography (HPLC) system was conﬁgured for reverse-phase chromatography
with a C18 column packed with Halo 2.7-m, 90-Å C18 material (MAC-MOD Analytical) and a ﬂow rate of
333 nl/min. Separation of peptides was performed using a gradient from 2 to 50% acetonitrile over 4 h,
followed by a 15-min wash with 95% acetonitrile, and a 15-min equilibration with 2% acetonitrile. The
eluate from HPLC was analyzed by an LTQ Velos Pro mass spectrometer (Thermo Scientiﬁc) using
nanospray ionization and parameters of one mass spectrometry (MS) scan followed by 10 tandem MS
(MS/MS) scans of the ﬁve most intense peaks. MS/MS scans were performed in pairs: a collision-induced
dissociation (CID) fragmentation scan followed by a higher-collision dissociation (HCD) fragmentation
scan of the same precursorm/z. Dynamic exclusion was enabled with a mass exclusion time of 3 min and
a repeat count of 1 within 30 s of initial m/z measurement. Spectra were collected over the entirety of
each 4-h chromatography run. Raw mass spectra were converted to MGF format using MSConvert, part
of the ProteoWizard software library (51). X!tandem 2013.09.01.1 (52) and OMSSA (open mass spectrom-
etry search algorithm) (53) algorithms were employed to perform MS/MS spectrum matching. Precursor
and fragment mass tolerance were set to 0.25 Da for both the OMSSA and X!tandem algorithms. Trypsin
cleavage rules were used for both algorithms with up to two missed cleavages. Amino acid modiﬁcations
searched consisted of single and double oxidation of methionine, oxidation of proline, N-terminal
acetylation, carbamidomethylation of cysteine, deamidation of asparagine and glutamine, and phos-
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phorylation of serine, threonine, and tyrosine. X!tandem xml and OMSSA xml results were ﬁltered using
Perl to remove any peptide matches with an E value of 0.01 as well as proteins identiﬁed by a single
peptide sequence. The protein fasta database for strain MNZ41 (GenBank accession no. ASJQ00000000.1)
was downloaded from the National Center for Biotechnology Information reference sequences (NCBI
RefSeq), and a randomized version of the MNZ41 fasta was concatenated to the original as a way to
assess data set quality and calculate false-discovery rates. The mass spectrometry proteomic data have
been deposited to the ProteomeXchange Consortium via the PRIDE partner repository (54) with the data
set identiﬁer PXD005178.
Strain MNZ41 and JLB01 proteomes were evaluated using differential expression analysis based on
peptide precursor mass ion current performed using the Perl programing language as described
previously (55). Brieﬂy, for each identiﬁed peptide, elution curves were integrated and organized by
protein and then technical replicate. Permutation tests were performed to determine whether any
differences between strains MNZ41 and JLB01 were signiﬁcant. A P value of 0.05 was used to indicate
signiﬁcance.
Flow cytometry. Pneumococcal cells were grown to mid-log phase, and 107 CFU of pneumococci
were pelleted by centrifugation and washed twice with 1 ml of PBS for all experiments. For human C3b
deposition, bacterial cells were suspended in 10% pooled human serum in gelatin-based veronal buffer
(0.15 mM CaCl2, 141 mM NaCl, 0.5 mM MgCl2, 0.1% gelatin, 1.8 mM sodium barbital, and 3.1 mM
barbituric acid [pH 7.3 to 7.4]) and allowed to incubate with rotation for 30 min at 37°C. Pneumococci
were subsequently collected, washed twice with PBS, and incubated with 200 l of 1 g/ml biotinylated
anti-human C3b (Cedarlane Laboratories Limited) for 30 min on ice. A serotype 2 ply, pspA, and pspC
deletion mutant (ΔPAC) known to strongly bind complement C3b was used as the positive control (31).
MNZ41 cells incubated without serum were used as the negative control. For binding to factor H,
bacterial cells were suspended in 200 l of 20 g/ml biotinylated factor H (obtained from Michael K.
Pangburn, University of Texas Health Science Center, USA) for 1 h on ice. Strain D39 (type 2) expressing
PspC known to bind to factor H (56) was used as a positive control for binding, and MNZ41 cells not
incubated with factor H were used as a negative control. For binding to nonspeciﬁc mouse IgA, bacterial
cells were incubated with 200 l of 10 g/ml nonspeciﬁc mouse IgA (Southern Biotech) for 1 h on ice,
washed twice with 500 l PBS, followed by 200 l of 5 g/ml biotinylated goat anti-mouse IgA for 30 min
on ice. MNZ41 cells incubated without mouse IgA were used as a negative control. For ﬂow cytometry
analysis, bacteria were collected, washed with PBS, stained with streptavidin-conjugated Alexa Fluor 488
(Invitrogen), and incubated on ice for 30 min with rotation in the dark. Following incubation, cells were
collected, washed with PBS three times, suspended in 500 l PBS, and analyzed by a NovoCyte ﬂow
cytometer with NovoSampler.
Ethics statement. All animal studies were performed in accordance with protocols reviewed and
approved by the University of Mississippi Medical Center Institutional Care and Use Committee (protocol
1361). The institution has an approved Animal Welfare Assurance on ﬁle with the Division of Assurances,
Ofﬁce of Laboratory Animal Welfare (OLAW) in compliance with the Public Health Service (PHS) Policy on
Humane Care and Use of Laboratory Animals.
Statistics. Results were analyzed using the InStat program (GraphPad PRISM 4 Software, San Diego,
CA). When two different strains were being compared, the nonparametric Mann-Whitney t test was used
for analysis. One-way analysis of variance (ANOVA) with Bonferroni posttest was applied when compar-
ing three or more strains. Flow cytometry statistics were provided by NovoExpress software (ACEA
Biosciences, San Diego, CA). Proteome statistics were performed as described above in “Comparative
proteomic analysis.”
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